Citadel Advisors’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.05M Buy
398,729
+240,370
+152% +$1.84M ﹤0.01% 5228
2025
Q4
$1.54M Buy
158,359
+38,127
+32% +$324K ﹤0.01% 6450
2025
Q3
$504K Sell
120,232
-157,242
-57% -$1M ﹤0.01% 9117
2025
Q2
$2.58M Buy
277,474
+254,719
+1,119% +$2.22M ﹤0.01% 5243
2025
Q1
$222K Sell
22,755
-113,609
-83% -$1.41M ﹤0.01% 10251
2024
Q4
$1.65M Buy
136,364
+585
+0.4% +$7.11K ﹤0.01% 6023
2024
Q3
$1.49M Sell
135,779
-79,107
-37% -$804K ﹤0.01% 6071
2024
Q2
$1.93M Buy
214,886
+147,446
+219% +$1.03M ﹤0.01% 5382
2024
Q1
$551K Sell
67,440
-140,097
-68% -$1.15M ﹤0.01% 8159
2023
Q4
$1.75M Sell
207,537
-989,498
-83% -$11.5M ﹤0.01% 5602
2023
Q3
$20.5M Buy
1,197,035
+60,917
+5% +$1.2M ﹤0.01% 1828
2023
Q2
$26.4M Buy
1,136,118
+21,206
+2% +$414K 0.01% 1604
2023
Q1
$19.7M Buy
1,114,912
+558,936
+101% +$13.3M ﹤0.01% 1931
2022
Q4
$15.1M Sell
555,976
-90,047
-14% -$1.87M ﹤0.01% 2274
2022
Q3
$11.2M Buy
646,023
+62,706
+11% +$1.2M ﹤0.01% 2617
2022
Q2
$10.2M Buy
583,317
+245,262
+73% +$4.03M ﹤0.01% 2664
2022
Q1
$5.74M Sell
338,055
-131,530
-28% -$2.48M ﹤0.01% 3912
2021
Q4
$12.7M Buy
469,585
+89,350
+23% +$2.67M ﹤0.01% 2668
2021
Q3
$11.3M Sell
380,235
-11,241
-3% -$365K ﹤0.01% 2868
2021
Q2
$15M Sell
391,476
-342,821
-47% -$11.7M ﹤0.01% 2468
2021
Q1
$22.4M Sell
734,297
-430,202
-37% -$16.1M 0.01% 1818
2020
Q4
$44.4M Buy
1,164,499
+714,087
+159% +$29.8M 0.01% 1041
2020
Q3
$10.4M Sell
450,412
-2,299
-0.5% -$52.4K ﹤0.01% 2255
2020
Q2
$11.3M Sell
452,711
-39,167
-8% -$693K ﹤0.01% 2086
2020
Q1
$4.9M Sell
491,878
-35,524
-7% -$530K ﹤0.01% 2732
2019
Q4
$7.57M Buy
527,402
+332,486
+171% +$4.79M ﹤0.01% 2540
2019
Q3
$2.71M Buy
194,916
+8,635
+5% +$106K ﹤0.01% 4006
2019
Q2
$2.73M Buy
186,281
+10,009
+6% +$145K ﹤0.01% 4012
2019
Q1
$2.68M Sell
176,272
-56,483
-24% -$704K ﹤0.01% 3963
2018
Q4
$2.33M Sell
232,755
-156,780
-40% -$2.12M ﹤0.01% 3916
2018
Q3
$6.27M Buy
+389,535
New +$6.83M ﹤0.01% 2695

Other funds holding REPL

Citadel Advisors's REPL Position: Q1 2026 in Review

Citadel Advisors increased its Replimune Group (REPL) stake by 152% in Q1 2026, buying an estimated $1.84M and bringing the position to 398,729 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #5228.

Citadel Advisors first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $44.4M in Q4 2020. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Citadel Advisors held 398,729 shares of Replimune Group worth $3.05M as of Q1 2026.
  • Citadel Advisors bought 240,370 Replimune Group shares in Q1 2026, an estimated $1.84M.
  • Replimune Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5228 holding.
  • Citadel Advisors first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Citadel Advisors's Replimune Group position peaked at $44.4M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.